As one of the top CROs in the field of cell therapy, Creative Biolabs has focused on the research of cancer therapies for years and has accomplished numerous challenging projects in this field. We used a unique T-cell antigen connector (TAC) technology to develop new TAC-T cells that can be directly targeted for control and low toxicity. Our TAC-specific T cells consist of DNA from tumor-specific targets, creating a novel T-cell receptor binding pathway and activating the T cells to kill the tumor.
Based on its ability to retarget and activate immune cells, TAC technology has great potential for treating both liquid and solid tumors. From raw materials to automated analytical equipment, Creative Biolabs is committed to providing innovative solutions that enable cell therapy to reach its maximum potential.
Fig. 1 FACS Analysis of scFv (TAC-T) in Different Cell Lines.
We can supply TAC-specific T cells from a variety of tumor-associated targets and can provide customized batches. Our cell products provide optimal assurance in terms of pH, purity, viral physical titer, and/or transduction titer, as well as sterility testing. In addition, we are working to develop corresponding in vitro cancer models. These new models are valuable for studying cancer and identifying and facilitating new cell therapy research.
With abundant experience in cell therapy development, Creative Biolabs can provide a full range of TAC-specific T cell products for the research of skin diseases. In addition, our experienced staff will work with you and help you with high-quality and cost-effective service to any projects of TAC-T cells. If you have already performed a part of a cell therapy project in your lab, we can also integrate the analysis and evaluation assays into your workflow. For additional details on our integrative fold recognition services, please free to contact us.
